References

  1. Sobel JD. Vulvovaginal candidosis. Lancet. 2007 Jun 9;369(9577):1961-1971. PubMed | Google Scholar

  2. Ane-Anyangwe I, Meriki HD, Silum SP, Nsongomanyi FR, Zofou D. Antifungal susceptibility profiles and risk factors of vaginal candidiasis amongst female university students in southwest region, Cameroon. Afr J Cln Exper Microbiol. 2015;16(1):67-72. Google Scholar

  3. Asticcioli S, Sacco L, Daturi R, Matti C, Nucleo E, Zara F et al. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in northern Italy during the years 2002-2007. New Microbiol. 2009 Apr;32(2):199-204. PubMed | Google Scholar

  4. Mohamadi J, Reza Havasian M, Panahi J, Pakzad I. Antifungal drug resistance pattern of Candida spp. isolated from vaginitis in Ilam-Iran during 2013-201 Bioinformation. 2015 Apr; 11(4):203-206. eCollection 2015. PubMed | Google Scholar

  5. Njunda AL, Nsagha DS, Assob JCN, Kamga HL, Teyim P. In vitro antifungal susceptibility patterns of Candida albicans from HIV and AIDS patients attending the Nylon Hospital in Douala Cameroon. J Public Health Africa. 2012 Mar 7;3(1):e2. PubMed | Google Scholar

  6. Sanguinetti M, Posteraro B, Lass-FlÖrl. Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses. 2015 Jun; 58(2):2-13. PubMed | Google Scholar

  7. Mbu ER, Kongnyuy EJ, Mbopi-Keou FX, Tonye RN, Nana PN, Leke RJI. Gynaecological morbidity among HIV positive pregnant women in Cameroon. Reproductive Health. 2008;5(3):1-5. PubMed | Google Scholar

  8. CLSI. Reference method for disk diffusion antifungal susceptibility testing of yeasts. Approved guideline second edition. CLSI document M44-A2. Wayne PA: clinical and laboratory standards institute 2009. (In press).

  9. Seddigheh Esmaeilzadeh, Saeid Mahdavi Omran Zr. Frequency and etiology of vulvovaginal candidiasis in women referred to a gynecological center in Babol, Iran. Royan Institute Int J fertile Steril. 2009;3(2):74-7. Google Scholar

  10. Pfaller MA, Diekema DJ, Gibbs DL et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: a 5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as dertermined by CLSI standardized disk diffusion. J Clin Microbiol. 2010 Apr;48(4):1366-77. PubMed | Google Scholar

  11. Mathema B, Cross E, Dun E, Park S, Bedell J, Slade B et al. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over the counter azole antifungals. Clin Infect Dis. 2001 Sep;33(5):23-7. PubMed | Google Scholar